Search for Patent: 6,303,607

Summary for Patent: 6,303,607

Title:	Method for administering a sustained release ranolanolazine formulation
Abstract:	A sustained release ranolazine formulation contains an intimate mixture of ranolazine and a partially neutralized pH-dependent binder to form a film that is mostly insoluble in aqueous media below pH 4.5 and soluble in aqueous media above pH 4.5. The formulation is suitable for twice daily administration of ranolazine and is useful for controlling the rate of dissolution of ranolazine, and to maintain human plasma ranolazine levels at between 550 and 7500 ng base/mL.
Inventor(s):	Wolff; Andrew A. (San Francisco, CA), Baker; Fiona (Dunfermline, GB), Langridge; John Richard (Wales, GB)
Assignee:	CV Therapeutics, Inc. (Palo Alto, CA)
Application Number:	09/321,522
Patent Claim Types:	Use; Composition; Dosage form;

Patent PDF download available with subscription

Glossary

Applicant	Tradename	Generic Name	NDA	Approval Date	Type	RLD	Patent Number	Product	Substance	Delist Req.	Patent Expiration	Patented / Exclusive Use
Gilead	RANEXA	ranolazine	021526	Feb 12, 2007	RX	Yes	6,303,607				May 27, 2019	TREATING CHRONIC ANGINA BY ADMINISTERING AN EXTENDED RELEASE FORM OF RANOLAZINE
Gilead	RANEXA	ranolazine	021526	Jan 27, 2006	RX	No	6,303,607				May 27, 2019	TREATING CHRONIC ANGINA BY ADMINISTERING AN EXTENDED RELEASE FORM OF RANOLAZINE

Export available with Ultimate Plan subscription:

This preview shows a limited data set. Complete access is available with a Subscription

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:
2000 2001 2002 2003 2004
2005 2006 2007 2008 2009

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Follow DrugPatentWatch on Twitter

Bookmark or Share This Page ...

Search for Patent: 6,303,607

Summary for Patent: 6,303,607

Glossary

<- Back to Dashboard

DrugPatentWatch Archives